Publication
Title
Bacteriophage therapy : advances in formulation strategies and human clinical trials
Author
Abstract
Recently, a number of phage therapy phase I and II safety trials have been concluded, showing no notable safety concerns associated with the use of phage. Though hurdles for efficient treatment remain, these trials hold promise for future phase III clinical trials. Interestingly, most phage formulations used in these clinical trials are straightforward phage suspensions and not much research has focused on the processing of phage cocktails in specific pharmaceutical dosage forms. Additional research on formulation strategies and stability of phage-based drugs will be of key importance, especially with phage therapy advancing towards phase III clinical trials.
Language
English
Source (journal)
Annual review of virology
Publication
2015
Volume/pages
2(2015), p. 599-618
ISI
000364397900027
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
External links
Web of Science
Record
Identification
Creation 19.10.2015
Last edited 11.09.2017